A detailed history of Global Retirement Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Global Retirement Partners, LLC holds 23,814 shares of BMY stock, worth $1.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
23,814
Previous 24,543 2.97%
Holding current value
$1.39 Million
Previous $1.02 Million 20.9%
% of portfolio
0.04%
Previous 0.03%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$39.66 - $51.75 $28,912 - $37,725
-729 Reduced 2.97%
23,814 $1.23 Million
Q2 2024

Jul 23, 2024

BUY
$40.25 - $52.99 $181,044 - $238,349
4,498 Added 22.44%
24,543 $1.02 Million
Q1 2024

Apr 23, 2024

BUY
$47.98 - $54.4 $15,785 - $17,897
329 Added 1.67%
20,045 $1.09 Million
Q4 2023

Jan 18, 2024

BUY
$48.48 - $57.85 $193 - $231
4 Added 0.02%
19,716 $1.01 Million
Q3 2023

Oct 13, 2023

SELL
$57.89 - $64.73 $58,758 - $65,700
-1,015 Reduced 4.9%
19,712 $1.14 Million
Q2 2023

Jul 20, 2023

BUY
$63.71 - $70.74 $100,215 - $111,274
1,573 Added 8.21%
20,727 $1.33 Million
Q1 2023

May 05, 2023

BUY
$65.71 - $74.53 $151,724 - $172,089
2,309 Added 13.71%
19,154 $1.33 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $70,055 - $82,955
1,023 Added 6.47%
16,845 $1.21 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $70,055 - $82,955
1,023 Added 6.47%
16,845 $1.21 Million
Q3 2022

Nov 03, 2022

BUY
$0.13 - $76.84 $18 - $10,988
143 Added 0.91%
15,822 $1.23 Million
Q2 2022

Jul 15, 2022

BUY
$72.62 - $79.98 $10,747 - $11,837
148 Added 0.95%
15,679 $1.21 Million
Q1 2022

Jul 14, 2022

BUY
$61.48 - $73.72 $954,845 - $1.14 Million
15,531 New
15,531 $1.2 Million
Q4 2021

Jan 21, 2022

SELL
$53.63 - $62.52 $424,374 - $494,720
-7,913 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$59.17 - $69.31 $24,259 - $28,417
410 Added 5.46%
7,913 $468,000
Q2 2021

Jul 15, 2021

BUY
$61.91 - $67.42 $2,352 - $2,561
38 Added 0.51%
7,503 $501,000
Q1 2021

Apr 14, 2021

SELL
$59.34 - $66.74 $39,164 - $44,048
-660 Reduced 8.12%
7,465 $471,000
Q4 2020

Jan 13, 2021

SELL
$57.74 - $65.43 $313,470 - $355,219
-5,429 Reduced 40.05%
8,125 $504,000
Q3 2020

Oct 09, 2020

SELL
$57.43 - $63.64 $2,871 - $3,182
-50 Reduced 0.37%
13,554 $817,000
Q2 2020

Jul 13, 2020

SELL
$54.82 - $64.09 $52,188 - $61,013
-952 Reduced 6.54%
13,604 $800,000
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $37,352 - $54,281
-805 Reduced 5.24%
14,556 $811,000
Q4 2019

Jan 23, 2020

BUY
$49.21 - $64.19 $66,384 - $86,592
1,349 Added 9.63%
15,361 $986,000
Q3 2019

Nov 19, 2019

BUY
$42.77 - $50.71 $31,778 - $37,677
743 Added 5.6%
14,012 $711,000
Q2 2019

Nov 19, 2019

BUY
$44.62 - $49.34 $202,217 - $223,608
4,532 Added 51.87%
13,269 $602,000
Q1 2019

May 07, 2019

BUY
$45.12 - $53.8 $6,361 - $7,585
141 Added 1.64%
8,737 $417,000
Q4 2018

Feb 22, 2019

SELL
$48.76 - $63.23 $50,125 - $65,000
-1,028 Reduced 10.68%
8,596 $447,000
Q3 2018

Oct 17, 2018

SELL
$55.19 - $62.25 $8,609 - $9,711
-156 Reduced 1.6%
9,624 $597,000
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $34,663 - $43,204
686 Added 7.54%
9,780 $541,000
Q1 2018

Aug 10, 2018

SELL
$59.92 - $68.98 $243,634 - $280,472
-4,066 Reduced 30.9%
9,094 $575,000
Q4 2017

Aug 13, 2018

BUY
$59.94 - $65.35 $642,736 - $700,748
10,723 Added 440.01%
13,160 $806,000
Q3 2017

Aug 10, 2018

SELL
$55.23 - $63.74 $9,941 - $11,473
-180 Reduced 6.88%
2,437 $155,000
Q2 2017

Aug 10, 2018

BUY
N/A
200 Added 8.27%
2,617 $146,000
Q1 2017

Aug 10, 2018

BUY
N/A
16 Added 0.67%
2,417 $131,000
Q4 2016

Aug 10, 2018

BUY
N/A
2,401
2,401 $140,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.